In a phase 1 trial, a PYY analogue (Y14 peptide) administered subcutaneously at 7- to 14-days intervals was safe and potentially efficacious (WL between 2.9 and 3.6 kg at 31 days, with a 3855% reduction in food intake vs
Magruder, a third-year resident at Maimonides Health in Brooklyn, NY and lead author of one of the presented studies, with the approval of semaglutide for the treatment of obesity by the FDA in 2021, and the surrounding media attention, it was clear that this medication was going to explode in popularity

Seek emergency care (call 999 or go to A&E) if you experience: Chest pain, stroke symptoms (face drooping, arm weakness, speech difficulties) Severe breathlessness Confusion or severe acute headache with very high blood pressure Fainting episodes Arrange same-day clinical review if: Your blood pressure reading is 180/120 mmHg, even without symptoms You have symptoms of hypotension : persistent dizziness, lightheadedness (especially upon standing), blurred vision, or unusual fatigue You have postural symptoms : feeling faint or dizzy when moving from sitting to standing Contact your GP or diabetes specialist nurse for routine concerns such as: Home blood pressure readings consistently at or above 135/85 mmHg (or clinic readings 140/90 mmHg) Home readings consistently below 90/60 mmHg Blood pressure readings that show significant variation from your usual pattern New or worsening symptoms that might be blood pressure-related, even if readings appear normal Persistent gastrointestinal symptoms (nausea, vomiting, diarrhoea) that may lead to dehydration Questions about adjusting antihypertensive medications as weight loss progresses Regular scheduled reviews with your healthcare team are essential for monitoring blood pressure trends and making appropriate medication adjustments

If the cause is irreversible then parental therapy should be continued for life